dr. W. Dieperink

Research

  1. 2019
  2. 2018
  3. SUP-ICU Trial Grp, Krag, M., Marker, S., Perner, A., Wetterslev, J., Wise, M. P., ... Dieperink, W. (2018). Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. New England Journal of Medicine, 379(23), 2199-2208. https://doi.org/10.1056/NEJMoa1714919
  4. The VIP1 Study Group, Guidet, B., Flaatten, H., Boumendil, A., Morandi, A., Andersen, F. H., ... de Lange, D. W. (2018). Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit. Intensive Care Medicine, 44(9), 1598-1601. https://doi.org/10.1007/s00134-018-5312-8
  5. 2017
  6. 2016
  7. Doesburg, F., Cnossen, F., Dieperink, W., Bult, W., & Nijsten, M. W. (2016). Improved usability of a multi-infusion setup using a central control display. 147-148. Poster session presented at 29th Annual Congress European Society of Intensive Care Medicine Milan, Milan, Italy. https://doi.org/10.1186/s40635-016-0098-x
  8. 2015
  9. 2014
  10. 2013
  11. Dijkema, M., Dieperink, W., Ligtenberg, J. J. M., & Zijlstra, J. G. (2013). PREDICT: PREDICTION OF READMISSION. Intensive Care Medicine, 39, S227-S228.
  12. 2012
  13. 2011
  14. Dijkema, LM., Dieperink, W., Heesink, A., & Zijlstra, J. G. (2011). EVALUATING (POTENTIAL) PREVENTABLE MORTALITY IN AN ADULT ICU. Intensive Care Medicine, 37, S137-S137.
  15. 2009
  16. 2008
  17. 2007
  18. 2006

ID: 21853447